Volume 69, Issue 4, Pages 624-633 (April 2016) The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis Patrizia Giannatempo, Gregory R. Pond, Guru Sonpavde, Daniele Raggi, Gurudatta Naik, Matthew D. Galsky, Joaquim Bellmunt, Andrea Necchi European Urology Volume 69, Issue 4, Pages 624-633 (April 2016) DOI: 10.1016/j.eururo.2015.09.051 Copyright © 2015 European Association of Urology Terms and Conditions
Fig. 1 Preferred Reporting Items for Systematic Reviews and meta-analysis flowchart. GU-ASCO=American Society of Clinical Oncology (Genitourinary Cancers Symposium); PICO=population, intervention, comparison, and outcome. European Urology 2016 69, 624-633DOI: (10.1016/j.eururo.2015.09.051) Copyright © 2015 European Association of Urology Terms and Conditions
Fig. 2 Forest plots of (A) overall survival of taxane studies, (B) overall survival of nontaxane studies, (C) overall survival of cisplatin studies, and (D) overall survival of carboplatin studies. RE=random effects. European Urology 2016 69, 624-633DOI: (10.1016/j.eururo.2015.09.051) Copyright © 2015 European Association of Urology Terms and Conditions